Ad is loading...
FSSNX
Price
$28.78
Change
-$0.41 (-1.40%)
Updated
Nov 15 closing price
RTOUX
Price
$43.46
Change
-$0.59 (-1.34%)
Updated
Nov 15 closing price
Ad is loading...

FSSNX vs RTOUX

Header iconFSSNX vs RTOUX Comparison
Open Charts FSSNX vs RTOUXBanner chart's image
Fidelity Small Cap Index
Price$28.78
Change-$0.41 (-1.40%)
VolumeN/A
CapitalizationN/A
Russell Inv Tax-Managed US Mid&Sm Cap M
Price$43.46
Change-$0.59 (-1.34%)
VolumeN/A
CapitalizationN/A
FSSNX vs RTOUX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSSNX vs. RTOUX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongSell and RTOUX is a Buy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 26.9B vs. RTOUX (1.7B). FSSNX pays higher dividends than RTOUX: FSSNX (1.36) vs RTOUX (0.18). FSSNX was incepted earlier than RTOUX: FSSNX (13 years) vs RTOUX (8 years). RTOUX is a more actively managed with annual turnover of: 71.00 vs. FSSNX (9.00). FSSNX (0) and RTOUX (0) have matching initial minimum investment requirements. FSSNX annual gain was more profitable for investors over the last year : 31.85 vs. RTOUX (26.04). RTOUX (47.72) and FSSNX (47.46) have equivalent 5 years return.
FSSNXRTOUXFSSNX / RTOUX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years8 years-
Gain YTD15.09011.322133%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets26.9B1.7B1,580%
Annual Yield % from dividends1.360.18751%
Returns for 1 year31.8526.04122%
Returns for 3 years-2.140.97-222%
Returns for 5 years47.4647.7299%
Returns for 10 years88.44N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPEV12.740.11
+0.87%
XPeng
EPC34.73-0.24
-0.69%
Edgewell Personal Care Company
NVO101.74-3.58
-3.40%
Novo-Nordisk A/S
GLUE7.74-0.74
-8.73%
Monte Rosa Therapeutics
GNLX2.36-0.58
-19.73%
Genelux Corp